Developer docs
API playgroundTry for free, no card

Search company profiles

BOC Sciences

Full company profile

uuid0006w2o

Namestring
BOC Sciences
Legal namestring
BOC Sciences
Websiteurl
bocsci.com
Company typeenum
Private
Founded yearint
2005
Descriptiontext

BOC Sciences is a privately held chemical supplier and contract development and manufacturing organization (CDMO) headquartered in Shirley, New York, with a European regional office in Frankfurt am Main, Germany. Founded in 2005, the company serves life sciences, biotechnology, and pharmaceutical clients across more than 60 countries, claiming over 6,000 global partners and more than a decade of continuous operation. Its customer base spans pharmaceutical companies, biotech firms, academic and research institutions, and vaccine and immunotherapy developers, served through a combination of self-service e-commerce, direct sales, and quote-based custom engagement.

The company's core offering is an integrated portfolio that combines catalog sales of research chemicals with custom synthesis and cGMP contract manufacturing. The catalog spans small-molecule inhibitors, PROTAC products, antibody-drug conjugates (ADCs), vaccine adjuvants, more than 20,000 pharmaceutical impurity reference standards, metabolites, GMP products, APIs (including US DMF- and EU DMF-approved anthracyclines), excipients, nucleosides, nucleotides, amino acids, chiral compounds, natural compounds, and specialty life science reagents. On the services side, BOC Sciences operates custom synthesis, microbial fermentation, analytical, bioconjugation, drug delivery (liposomes, nanoparticles, mRNA/siRNA delivery), and CDMO capabilities at scales from 1kg to 1,000kg. It has also built proprietary technology platforms branded as BOC Nano™, APOC™, GlycoAOCT™, and LipCeDS™, and recently launched the Glycan Portal (October 2025) to support glycoscience research.

BOC Sciences generates revenue through multiple streams: catalog product sales priced by unit and purity, quote-based custom synthesis projects, multi-year CDMO contracts for cGMP manufacturing, professional services for AI-assisted drug discovery, and emerging technology licensing through its APOC/GlycoAOCT/LipCeDS programs. Pricing is primarily quote-based for custom and bulk orders, with reference catalog unit prices ranging from approximately $197 to $1,999 depending on product, purity, and quantity. Demand generation is led by an SEO-optimized product catalog, technical blog content, webinars, social media presence, and conference participation, while order capture is handled through direct phone/email channels and an online inquiry basket on bocsci.com.

Short descriptiontext

BOC Sciences is a privately held chemical supplier and CDMO serving pharmaceutical, biotechnology, academic, and life sciences clients worldwide with research chemicals, custom synthesis, cGMP manufacturing, and emerging drug discovery and drug delivery platforms.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersShirley, United States
HQ citystring
Shirley
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
research chemicals supply, pharmaceutical CDMO services, custom chemical synthesis, PROTAC drug discovery, antibody-drug conjugates
Industry5 codes
PRIMARYHLAIABAI
Contract Development & Manufacturing for Generics (CDMO/CMO)
SECONDARYHLAGAHAG
Impurity / Reference Standard Synthesis & Characterization
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/API & Small-Molecule Development/Manufacturing Services
SECONDARYHLAGAHAM
Small-Molecule CMC Documentation & Regulatory Support (DMF/CMC)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/API & Small-Molecule Development/Manufacturing Services
SECONDARYHLAGAFAC
DMPK / ADME & Bioanalysis
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Preclinical Services (Toxicology/Pharmacology/DMPK)
SECONDARYHLAGAGAC
mRNA & Nucleic Acid Manufacturing Services (mRNA/saRNA/Plasmid DNA)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Biopharma Manufacturing Services (Biologics/Cell & Gene)
NAICS code4 codes
  • Pharmaceutical and Medicine Manufacturing3254
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
  • Pharmaceutical and Medicine Manufacturing32541
  • Pharmaceutical Preparation Manufacturing325412
SIC code4 codes
  • Services-Commercial Physical & Biological Research8731
  • Pharmaceutical Preparations2834
  • Medicinal Chemicals & Botanical Products2833
  • Wholesale-Drugs, Proprietaries & Druggists' Sundries5122
Product category
Pharmaceutical Contract Manufacturing & Research Chemicals
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model5 records
1Research Chemicals & Products Sales
TypeOne Time License
Description

BOC Sciences generates revenue through the sale of research chemicals including small-molecule inhibitors, pharmaceutical impurities, metabolites, intermediates, APIs, GMP products, natural compounds, amino acids, nucleotides, and life science products. Products are sold in research-grade to GMP-compliant specifications ranging from milligrams to commercial kilogram quantities.

bocsci.com
2Custom Synthesis Services
TypeProfessional Services
Description

Revenue from bespoke chemical synthesis services including custom synthesis of pharmaceutical intermediates, metabolites, isotope-labeled compounds, nucleoside/nucleotide intermediates, and heterocyclic compounds. Services include chiral synthesis, resolution, and process optimization.

bocsci.com
3CDMO Services
TypeManaged Services
Description

Contract Development and Manufacturing Organization services including cGMP manufacturing (small scale 1kg to commercial quantities 1000kg), CMC, formulation services, process development, and quality control for pharmaceutical clients.

bocsci.com
4AI Drug Discovery Services
TypeProfessional Services
Description

AI-powered drug discovery and preclinical development services including conjugated drug development, RNA therapeutics development, and ADMET prediction with developability assessment.

bocsci.com
5Drug Delivery Solutions
TypeProfessional Services
Description

Specialized drug delivery platform services including cell-based delivery, hydrogel delivery, liposome delivery, microspheres, nanoparticle delivery, peptide-based delivery, polymer-based delivery, exosome-based delivery, mRNA delivery, siRNA delivery, and carbohydrate-based delivery systems.

bocsci.com
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Supply Chain, Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure
Pricing details3 tiers
1Standard Research Chemicals
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Individual product pricing displayed on website with quantities ranging from mg to kg scale. Examples: $197-$659 for amino acids, $298-$1999 for pharmaceutical excipients, $398-$1999 for APIs. Price varies by product, purity level, and quantity ordered.

bocsci.com
2Custom Synthesis Services
ModelOtherBilling cadencePay-as-you-go
Notes

Quote-based pricing for custom synthesis services. Pricing determined by project complexity, required purity, quantity, and timeline. Payment methods include credit card (by phone), check, wire transfer, or ACH.

bocsci.com
3cGMP Manufacturing
ModelUnit PricingBilling cadenceMulti-year contract
Notes

Contract manufacturing organization services from small scale (1kg) to commercial quantities (1000kg). Pricing determined by scale, complexity, and regulatory requirements. cGMP capacity supports pharmaceutical development through commercial production.

bocsci.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 5 records shown
1BOC NanoTM Platform
Description

Nanotechnology platform for drug delivery and nanoparticle development services

bocsci.com
+4 more records
Core offering1 text field

BOC Sciences manufactures and supplies a broad catalog of research chemicals, pharmaceutical intermediates, impurities, metabolites, amino acids, nucleotides, oligonucleotides, enzymes, excipients, APIs, and GMP-compliant products for pharmaceutical, biotechnology, and academic research customers. It also delivers contract development and manufacturing organization (CDMO) services, custom synthesis, bioconjugation, analytical services, drug delivery solutions, and AI-powered drug discovery across advanced therapeutic modalities including PROTAC, ADC, RNA, and nanotechnology.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Serving clients in more than 60 countries worldwide
+2 more records
Product overview1 text field

BOC Sciences is a diversified chemical and pharmaceutical company offering an integrated portfolio of research chemicals, APIs, and contract services. The core product lines include small-molecule inhibitors, PROTAC products, vaccine adjuvants, pharmaceutical impurity standards (20,000+ products), metabolites, antibody-drug conjugates (ADCs), pharmaceutical excipients, APIs, GMP products, chemical intermediates, amino acids, chiral compounds, natural compounds, nucleotides, oligonucleotides, enzymes, and phospholipids. The service portfolio encompasses AI drug discovery, microbial fermentation, drug delivery solutions (including liposomes, nanoparticles, mRNA/siRNA delivery), custom synthesis, bioconjugation, analytical services, and CDMO services. The company operates under GMP-compliant and ISO-certified standards, serving clients in more than 60 countries. The Glycan Portal (launched October 2025) represents their latest product initiative in glycoscience.

Product and service34 records
1Small-Molecule Inhibitors
CategoryDrug Discovery Research Chemicals
Description

High-purity small-molecule inhibitors, agonists and modulators synthesized to research-grade or GMP-compliant specifications for precision-targeted drug discovery and screening, available from milligrams to kilograms.

2PseudoUridine
CategoryNucleic Acid Building Blocks
Description

Bulk PseudoUridine and derivatives for global R&D and manufacturing, optimized for mRNA vaccine development and nucleic acid research.

3Nucleosides & Nucleotides
CategoryNucleic Acid Building Blocks
Description

Biograde nucleosides and nucleotides in research and production-scale quantities for mRNA therapeutics and oligonucleotide production.

4PROTAC Products
CategoryDrug Discovery Research Chemicals
Description

PROTAC molecular discovery products including E3 ligase ligands, linkers, and target protein ligands for targeted protein degradation drug discovery.

5Vaccine Adjuvants
CategoryVaccine Development Materials
Description

Comprehensive vaccine adjuvant products including aluminum salts, cytokines, saponins, CpG oligonucleotides, liposome adjuvants, oil emulsion adjuvants, and polymer nanoparticles for human and animal vaccine development.

6Pharmaceutical Impurity Standards
CategoryPharmaceutical Reference Standards
Description

Over 20,000 pharmaceutical impurity products including API-related impurities, degradation products, process-related impurities, metabolites, nitrosamine impurities, and chiral impurities with COA/HPLC/MS/NMR documentation.

7Metabolites
CategoryDrug Discovery Research Chemicals
Description

High-purity primary and secondary metabolites from microbial sources (Actinoplanes, Aspergillus, Bacillus, Streptomyces, and others) and analogue sets for various antibiotic classes.

8Antibody-Drug Conjugate (ADC) Products & Services
CategoryADC Therapeutics
Description

Complete suite of ADC offerings including antibody modification and conjugation technologies, ADC payload and payload-linker synthesis, ADC conjugation, characterization, and manufacturing.

9Pharmaceutical Excipients
CategoryPharmaceutical Formulation Materials
Description

Pharmaceutical-grade excipients including fillers, diluents, binders, suspension agents, coatings, flavoring agents, disintegrants, colorants, lubricants, preservatives, sweeteners, and emulsifiers.

10Active Pharmaceutical Ingredients (APIs)
CategoryActive Pharmaceutical Ingredients
Description

Synthetic, biological, plant-derived, and radiopharmaceutical APIs including anthracyclines such as Daunorubicin HCl, Doxorubicin HCl, Epirubicin HCl (with US DMF and EU DMF), and Valrubicin.

11GMP Products
CategoryGMP-Compliant Compounds
Description

Good Manufacturing Practice compliant products including GMP Cholesterol, GMP Guanosine-5'-triphosphate, GMP Imiquimod, GMP Paclitaxel, GMP Docetaxel, and other pharmaceutical-grade compounds.

12Chemical Intermediates
CategoryChemical Intermediates
Description

High-quality chemical intermediates including pharmaceutical, pesticide, and polymer intermediates supporting research, development, and industrial production.

13Amino Acids
CategoryChemistry Building Blocks
Description

Comprehensive amino acid catalog including D-, L-, DL-, β-, γ-amino acids, Fmoc-, BOC-, CBZ-amino acids, cyclic, fluorinated, and unnatural amino acids.

14Chiral Compounds
CategoryChemistry Building Blocks
Description

Chiral compounds supporting stereochemical control in pharmaceutical research and development.

15Natural Compounds
CategoryChemistry Building Blocks
Description

Natural compounds extracted from microorganisms or plants for analytical testing and various industry applications.

16Stable Isotope Labelled Compounds
CategoryChemistry Building Blocks
Description

Isotope-labeled compounds for metabolic studies and analytical chemistry research applications.

17Flavor & Fragrance Compounds
CategorySpecialty Chemicals
Description

Flavor and fragrance compounds for food, beverage, and cosmetic industry applications.

18Superparamagnetic Iron Oxide Nano/Micro Particles
CategoryNanomaterials
Description

Nano and micro superparamagnetic iron oxide particles prepared for research and industrial applications.

19Nanoemulsions
CategoryNanomaterials
Description

Nanoscale emulsions (20–200 nm droplet size) stabilized by surfactants for pharmaceutical, food, cosmetics, and industrial applications.

20Oligonucleotides
CategoryNucleic Acid Building Blocks
Description

Synthetically produced short strands of nucleotides (2–50 nucleotides) for research, diagnostics, and therapeutic applications.

21Enzymes
CategoryLife Science Reagents
Description

High-purity enzymes for research, diagnostics, and industrial applications including glycobiology, molecular biology, clinical chemistry, and metabolic analysis.

22Stem Cell Molecules
CategoryDrug Discovery Research Chemicals
Description

Small molecules with high selectivity and stable physicochemical properties for stem cell biology including induced differentiation, reprogramming, and transdifferentiation.

23Fluorescent Probes
CategoryLife Science Reagents
Description

Single fluorophores and fluorophores covalently bound to biomolecules, including cell and organelle stains, DNA stains, fluorescent enzyme substrates, ion indicators, and pH indicators.

24Chemiluminescent Substrates
CategoryLife Science Reagents
Description

Chemiluminescent agents that transfer energy in chemical reactions to release light, used as detection tools for proteins and nucleic acids.

25Phospholipids
CategorySpecialty Chemicals
Description

Amphiphilic lipids with glycerol or sphingosine backbones used as emulsifiers and dispersants in cosmetics, food, nutrition, and pharmaceutical formulations.

26Microbial Fermentation Services
CategoryContract Manufacturing Services
Description

Contract manufacturing services for custom microbial solutions supporting biopharma, agriculture, and synthetic biology applications.

27AI Drug Discovery Services
CategoryDrug Discovery Services
Description

AI-powered drug discovery and preclinical development services including conjugated drug development, RNA therapeutics development, and ADMET prediction with developability assessment.

28Drug Delivery Solutions
CategoryDrug Delivery Services
Description

Drug delivery services spanning cell-based, hydrogel, liposome, microsphere, nanoparticle, peptide-based, polymer-based, exosome-based, carbohydrate-based, mRNA, RNA, and siRNA delivery modalities.

29RNA Technology Services
CategoryDrug Discovery Services
Description

RNA technology services including nucleoside synthesis, nucleotide synthesis, and custom RNA synthesis for therapeutics development.

30Custom Synthesis Services
CategoryCustom Synthesis Services
Description

Custom synthesis services including glycogen, glycans, chiral resolution, nucleoside, nucleotide, and carbohydrate synthesis.

31Bioconjugation Services
CategoryCustom Synthesis Services
Description

Bioconjugation services including isotope labeling and fluorescent labeling of proteins.

32CDMO Services
CategoryContract Manufacturing Services
Description

Contract Development and Manufacturing Organization services including cGMP capacity (1 kg to 1,000 kg), ingredient combination, CMC, formulation services, process development, and quality control.

33Analytical Services
CategoryAnalytical Services
Description

Analytical services including XDC analysis, crystallization services, lab testing, animal testing for inhibitors, contract purification, and impurity identification and analysis.

34Glycan Portal
CategoryGlycoscience Research Portal
Description

Online portal launched in October 2025 to support glycoscience research, development, and commercialization, providing reagents and services for therapeutics, diagnostics, and biomarker discovery.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Recent move3 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Global CRO/CDMO offering custom synthesis, small-molecule CMC, APIs, and impurity reference standards with extensive GMP capacity. WuXi AppTec is the closest direct competitor to BOC Sciences' combined research-chemical and CDMO model, though at significantly larger scale.

TypeBroad incumbent
Description

World's largest research chemicals supplier offering hundreds of thousands of catalog products including impurities, intermediates, and reagents. Comparable to BOC Sciences' catalog business at vastly greater scale and broader portfolio including life science tools and biopharma services.

TypeDirect peer
Description

Tokyo Chemical Industry is a direct competitor in research chemicals, organic intermediates, and custom synthesis with a similarly global distribution footprint. Comparable product catalog depth and target customers in pharma, biotech, and academic research.

TypeDirect peer
Description

Direct competitor focused on building blocks, custom synthesis, and reference standards for pharma and biotech research. Comparable business model combining catalog sales with custom synthesis services targeting drug discovery customers.

TypeDirect peer
Description

China-based chemical supplier and CDMO offering building blocks, intermediates, APIs, and custom synthesis. A direct competitor to BOC Sciences' research chemicals and impurity standards business with cost-competitive positioning.

TypeBroad incumbent
Description

Large global CDMO providing formulation, drug delivery, and commercial manufacturing services across small molecules and biologics. Comparable to BOC Sciences' CDMO and drug delivery platforms (nanoparticles, liposomes) but at significantly greater commercial scale.

TypeBroad incumbent
Description

Global CDMO leader offering small-molecule APIs, biologics manufacturing, and cell & gene therapy services. Comparable to BOC Sciences' CDMO/API business and mRNA manufacturing platforms, though at vastly larger scale and broader modality coverage.

8Santa Cruz Biotechnology
TypeDirect peer
Description

Supplier of research reagents including antibodies, biochemicals, and small-molecule inhibitors for life science research. Directly comparable to BOC Sciences' small-molecule inhibitors, fluorescent probes, and research chemicals product lines targeting academic and biotech researchers.

TypeBroad incumbent
Description

Public life science tools company offering reagents, proteins, antibodies, and GMP-grade cytokines for research and cell therapy manufacturing. Comparable to BOC Sciences' GMP products and life science reagents portfolio with deeper biologics focus and stronger brand.

TypeEmerging player
Description

Specialized CDMO focused on peptide and oligonucleotide API manufacturing with cGMP capabilities. Comparable to BOC Sciences' custom synthesis and CDMO capabilities for peptide-based and oligonucleotide chemistries, though with deeper specialization in peptide API manufacturing.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers4 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

BOC Sciences

Pharmaceutical Contract Manufacturing & Research Chemicalsbocsci.com

BOC Sciences is a privately held chemical supplier and CDMO serving pharmaceutical, biotechnology, academic, and life sciences clients worldwide with research chemicals, custom synthesis, cGMP manufacturing, and emerging drug discovery and drug delivery platforms.

What BOC Sciences does

BOC Sciences is a privately held chemical supplier and contract development and manufacturing organization (CDMO) headquartered in Shirley, New York, with a European regional office in Frankfurt am Main, Germany. Founded in 2005, the company serves life sciences, biotechnology, and pharmaceutical clients across more than 60 countries, claiming over 6,000 global partners and more than a decade of continuous operation. Its customer base spans pharmaceutical companies, biotech firms, academic and research institutions, and vaccine and immunotherapy developers, served through a combination of self-service e-commerce, direct sales, and quote-based custom engagement.

The company's core offering is an integrated portfolio that combines catalog sales of research chemicals with custom synthesis and cGMP contract manufacturing. The catalog spans small-molecule inhibitors, PROTAC products, antibody-drug conjugates (ADCs), vaccine adjuvants, more than 20,000 pharmaceutical impurity reference standards, metabolites, GMP products, APIs (including US DMF- and EU DMF-approved anthracyclines), excipients, nucleosides, nucleotides, amino acids, chiral compounds, natural compounds, and specialty life science reagents. On the services side, BOC Sciences operates custom synthesis, microbial fermentation, analytical, bioconjugation, drug delivery (liposomes, nanoparticles, mRNA/siRNA delivery), and CDMO capabilities at scales from 1kg to 1,000kg. It has also built proprietary technology platforms branded as BOC Nano™, APOC™, GlycoAOCT™, and LipCeDS™, and recently launched the Glycan Portal (October 2025) to support glycoscience research.

BOC Sciences generates revenue through multiple streams: catalog product sales priced by unit and purity, quote-based custom synthesis projects, multi-year CDMO contracts for cGMP manufacturing, professional services for AI-assisted drug discovery, and emerging technology licensing through its APOC/GlycoAOCT/LipCeDS programs. Pricing is primarily quote-based for custom and bulk orders, with reference catalog unit prices ranging from approximately $197 to $1,999 depending on product, purity, and quantity. Demand generation is led by an SEO-optimized product catalog, technical blog content, webinars, social media presence, and conference participation, while order capture is handled through direct phone/email channels and an online inquiry basket on bocsci.com.

BOC Sciences firmographics

Firmographics
Name
BOC Sciences
Legal name
BOC Sciences
Website
https://bocsci.com
Company type
Private
Founded year
2005
Operating status
Operating
Headcount range
11–50 employees
Short description
BOC Sciences is a privately held chemical supplier and CDMO serving pharmaceutical, biotechnology, academic, and life sciences clients worldwide with research chemicals, custom synthesis, cGMP manufacturing, and emerging drug discovery and drug delivery platforms.
Ownership category
akta.pro rank

BOC Sciences industry classification

Industry
Product category
Pharmaceutical Contract Manufacturing & Research Chemicals
NAICS
Pharmaceutical and Medicine Manufacturing (3254), Research and Development in Biotechnology (except Nanobiotechnology) (541714), Pharmaceutical and Medicine Manufacturing (32541), Pharmaceutical Preparation Manufacturing (325412)
SIC
Services-Commercial Physical & Biological Research (8731), Pharmaceutical Preparations (2834), Medicinal Chemicals & Botanical Products (2833), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)
akta.pro industry
PRIMARYHLAIABAI
Contract Development & Manufacturing for Generics (CDMO/CMO)
SECONDARYHLAGAHAG
Impurity / Reference Standard Synthesis & Characterization
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/API & Small-Molecule Development/Manufacturing Services
SECONDARYHLAGAHAM
Small-Molecule CMC Documentation & Regulatory Support (DMF/CMC)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/API & Small-Molecule Development/Manufacturing Services
SECONDARYHLAGAFAC
DMPK / ADME & Bioanalysis
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Preclinical Services (Toxicology/Pharmacology/DMPK)
SECONDARYHLAGAGAC
mRNA & Nucleic Acid Manufacturing Services (mRNA/saRNA/Plasmid DNA)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Biopharma Manufacturing Services (Biologics/Cell & Gene)

Keywords

  • Research chemicals supply
  • Pharmaceutical CDMO services
  • Custom chemical synthesis
  • PROTAC drug discovery
  • Antibody-drug conjugates

Where BOC Sciences is headquartered

Location

Headquarters

HQ city
Shirley
HQ country
United States
HQ region
North America

Offices2 records

Markets served

BOC Sciences business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

  1. Research Chemicals & Products Sales: BOC Sciences generates revenue through the sale of research chemicals including small-molecule inhibitors, pharmaceutical impurities, metabolites, intermediates, APIs, GMP products, natural compounds, amino acids, nucleotides, and life science products. Products are sold in research-grade to GMP-compliant specifications ranging from milligrams to commercial kilogram quantities.
  2. Custom Synthesis Services: Revenue from bespoke chemical synthesis services including custom synthesis of pharmaceutical intermediates, metabolites, isotope-labeled compounds, nucleoside/nucleotide intermediates, and heterocyclic compounds. Services include chiral synthesis, resolution, and process optimization.
  3. CDMO Services: Contract Development and Manufacturing Organization services including cGMP manufacturing (small scale 1kg to commercial quantities 1000kg), CMC, formulation services, process development, and quality control for pharmaceutical clients.
  4. AI Drug Discovery Services: AI-powered drug discovery and preclinical development services including conjugated drug development, RNA therapeutics development, and ADMET prediction with developability assessment.
  5. Drug Delivery Solutions: Specialized drug delivery platform services including cell-based delivery, hydrogel delivery, liposome delivery, microspheres, nanoparticle delivery, peptide-based delivery, polymer-based delivery, exosome-based delivery, mRNA delivery, siRNA delivery, and carbohydrate-based delivery systems.

Pricing tiers

ModelBillingPrice
Unit PricingPay-as-you-goStandard Research Chemicals
OtherPay-as-you-goCustom Synthesis Services
Unit PricingMulti-year contractcGMP Manufacturing

Go-to-market motion1 record

Distribution channels3 records

Marketing channels7 records

BOC Sciences product offering

Product offering

Core offering

BOC Sciences manufactures and supplies a broad catalog of research chemicals, pharmaceutical intermediates, impurities, metabolites, amino acids, nucleotides, oligonucleotides, enzymes, excipients, APIs, and GMP-compliant products for pharmaceutical, biotechnology, and academic research customers. It also delivers contract development and manufacturing organization (CDMO) services, custom synthesis, bioconjugation, analytical services, drug delivery solutions, and AI-powered drug discovery across advanced therapeutic modalities including PROTAC, ADC, RNA, and nanotechnology.

Product overview

BOC Sciences is a diversified chemical and pharmaceutical company offering an integrated portfolio of research chemicals, APIs, and contract services. The core product lines include small-molecule inhibitors, PROTAC products, vaccine adjuvants, pharmaceutical impurity standards (20,000+ products), metabolites, antibody-drug conjugates (ADCs), pharmaceutical excipients, APIs, GMP products, chemical intermediates, amino acids, chiral compounds, natural compounds, nucleotides, oligonucleotides, enzymes, and phospholipids. The service portfolio encompasses AI drug discovery, microbial fermentation, drug delivery solutions (including liposomes, nanoparticles, mRNA/siRNA delivery), custom synthesis, bioconjugation, analytical services, and CDMO services. The company operates under GMP-compliant and ISO-certified standards, serving clients in more than 60 countries. The Glycan Portal (launched October 2025) represents their latest product initiative in glycoscience.

Differentiator

Problem solved

Functional benefit

Brands

  • BOC NanoTM Platform: Nanotechnology platform for drug delivery and nanoparticle development services
  • Glycan Portal
  • APOC™ (Antibody Peptide Oligonucleotide Conjugation)
  • GlycoAOCT™ (Glycosylated Antibody-Oligonucleotide Conjugates Technology)
  • LipCeDS™ (Lipid-based Chem Enhanced Delivery System)

Products and services

  • Small-Molecule Inhibitors High-purity small-molecule inhibitors, agonists and modulators synthesized to research-grade or GMP-compliant specifications for precision-targeted drug discovery and screening, available from milligrams to kilograms.
  • PseudoUridine Bulk PseudoUridine and derivatives for global R&D and manufacturing, optimized for mRNA vaccine development and nucleic acid research.
  • Nucleosides & Nucleotides Biograde nucleosides and nucleotides in research and production-scale quantities for mRNA therapeutics and oligonucleotide production.
  • PROTAC Products PROTAC molecular discovery products including E3 ligase ligands, linkers, and target protein ligands for targeted protein degradation drug discovery.
  • Vaccine Adjuvants Comprehensive vaccine adjuvant products including aluminum salts, cytokines, saponins, CpG oligonucleotides, liposome adjuvants, oil emulsion adjuvants, and polymer nanoparticles for human and animal vaccine development.
  • Pharmaceutical Impurity Standards Over 20,000 pharmaceutical impurity products including API-related impurities, degradation products, process-related impurities, metabolites, nitrosamine impurities, and chiral impurities with COA/HPLC/MS/NMR documentation.
  • Metabolites High-purity primary and secondary metabolites from microbial sources (Actinoplanes, Aspergillus, Bacillus, Streptomyces, and others) and analogue sets for various antibiotic classes.
  • Antibody-Drug Conjugate (ADC) Products & Services Complete suite of ADC offerings including antibody modification and conjugation technologies, ADC payload and payload-linker synthesis, ADC conjugation, characterization, and manufacturing.
  • Pharmaceutical Excipients Pharmaceutical-grade excipients including fillers, diluents, binders, suspension agents, coatings, flavoring agents, disintegrants, colorants, lubricants, preservatives, sweeteners, and emulsifiers.
  • Active Pharmaceutical Ingredients (APIs) Synthetic, biological, plant-derived, and radiopharmaceutical APIs including anthracyclines such as Daunorubicin HCl, Doxorubicin HCl, Epirubicin HCl (with US DMF and EU DMF), and Valrubicin.
  • GMP Products Good Manufacturing Practice compliant products including GMP Cholesterol, GMP Guanosine-5'-triphosphate, GMP Imiquimod, GMP Paclitaxel, GMP Docetaxel, and other pharmaceutical-grade compounds.
  • Chemical Intermediates High-quality chemical intermediates including pharmaceutical, pesticide, and polymer intermediates supporting research, development, and industrial production.
  • Amino Acids Comprehensive amino acid catalog including D-, L-, DL-, β-, γ-amino acids, Fmoc-, BOC-, CBZ-amino acids, cyclic, fluorinated, and unnatural amino acids.
  • Chiral Compounds Chiral compounds supporting stereochemical control in pharmaceutical research and development.
  • Natural Compounds Natural compounds extracted from microorganisms or plants for analytical testing and various industry applications.
  • Stable Isotope Labelled Compounds Isotope-labeled compounds for metabolic studies and analytical chemistry research applications.
  • Flavor & Fragrance Compounds Flavor and fragrance compounds for food, beverage, and cosmetic industry applications.
  • Superparamagnetic Iron Oxide Nano/Micro Particles Nano and micro superparamagnetic iron oxide particles prepared for research and industrial applications.
  • Nanoemulsions Nanoscale emulsions (20–200 nm droplet size) stabilized by surfactants for pharmaceutical, food, cosmetics, and industrial applications.
  • Oligonucleotides Synthetically produced short strands of nucleotides (2–50 nucleotides) for research, diagnostics, and therapeutic applications.
  • Enzymes High-purity enzymes for research, diagnostics, and industrial applications including glycobiology, molecular biology, clinical chemistry, and metabolic analysis.
  • Stem Cell Molecules Small molecules with high selectivity and stable physicochemical properties for stem cell biology including induced differentiation, reprogramming, and transdifferentiation.
  • Fluorescent Probes Single fluorophores and fluorophores covalently bound to biomolecules, including cell and organelle stains, DNA stains, fluorescent enzyme substrates, ion indicators, and pH indicators.
  • Chemiluminescent Substrates Chemiluminescent agents that transfer energy in chemical reactions to release light, used as detection tools for proteins and nucleic acids.
  • Phospholipids Amphiphilic lipids with glycerol or sphingosine backbones used as emulsifiers and dispersants in cosmetics, food, nutrition, and pharmaceutical formulations.
  • Microbial Fermentation Services Contract manufacturing services for custom microbial solutions supporting biopharma, agriculture, and synthetic biology applications.
  • AI Drug Discovery Services AI-powered drug discovery and preclinical development services including conjugated drug development, RNA therapeutics development, and ADMET prediction with developability assessment.
  • Drug Delivery Solutions Drug delivery services spanning cell-based, hydrogel, liposome, microsphere, nanoparticle, peptide-based, polymer-based, exosome-based, carbohydrate-based, mRNA, RNA, and siRNA delivery modalities.
  • RNA Technology Services RNA technology services including nucleoside synthesis, nucleotide synthesis, and custom RNA synthesis for therapeutics development.
  • Custom Synthesis Services Custom synthesis services including glycogen, glycans, chiral resolution, nucleoside, nucleotide, and carbohydrate synthesis.
  • Bioconjugation Services Bioconjugation services including isotope labeling and fluorescent labeling of proteins.
  • CDMO Services Contract Development and Manufacturing Organization services including cGMP capacity (1 kg to 1,000 kg), ingredient combination, CMC, formulation services, process development, and quality control.
  • Analytical Services Analytical services including XDC analysis, crystallization services, lab testing, animal testing for inhibitors, contract purification, and impurity identification and analysis.
  • Glycan Portal Online portal launched in October 2025 to support glycoscience research, development, and commercialization, providing reagents and services for therapeutics, diagnostics, and biomarker discovery.

Quantifiable outcome

  • Serving clients in more than 60 countries worldwide
  • +2 more outcomes

Companies that use BOC Sciences

Customer profile

Named customers4 records

Segments4 records

Ideal customer profiles2 records

BOC Sciences technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature6 records

BOC Sciences partnerships and signals

Strategic signal

Scale indicators3 records

Recent moves3 records

Expansion highlights6 records

BOC Sciences competitors and assessment

Company assessment

Direct peers

  • WuXi AppTec: Global CRO/CDMO offering custom synthesis, small-molecule CMC, APIs, and impurity reference standards with extensive GMP capacity. WuXi AppTec is the closest direct competitor to BOC Sciences' combined research-chemical and CDMO model, though at significantly larger scale.
  • TCI Chemicals: Tokyo Chemical Industry is a direct competitor in research chemicals, organic intermediates, and custom synthesis with a similarly global distribution footprint. Comparable product catalog depth and target customers in pharma, biotech, and academic research.
  • Combi-Blocks: Direct competitor focused on building blocks, custom synthesis, and reference standards for pharma and biotech research. Comparable business model combining catalog sales with custom synthesis services targeting drug discovery customers.
  • Bide Pharmatech: China-based chemical supplier and CDMO offering building blocks, intermediates, APIs, and custom synthesis. A direct competitor to BOC Sciences' research chemicals and impurity standards business with cost-competitive positioning.
  • Santa Cruz Biotechnology: Supplier of research reagents including antibodies, biochemicals, and small-molecule inhibitors for life science research. Directly comparable to BOC Sciences' small-molecule inhibitors, fluorescent probes, and research chemicals product lines targeting academic and biotech researchers.

Broad incumbents

  • Sigma-Aldrich (Merck KGaA / MilliporeSigma): World's largest research chemicals supplier offering hundreds of thousands of catalog products including impurities, intermediates, and reagents. Comparable to BOC Sciences' catalog business at vastly greater scale and broader portfolio including life science tools and biopharma services.
  • Catalent: Large global CDMO providing formulation, drug delivery, and commercial manufacturing services across small molecules and biologics. Comparable to BOC Sciences' CDMO and drug delivery platforms (nanoparticles, liposomes) but at significantly greater commercial scale.
  • Lonza: Global CDMO leader offering small-molecule APIs, biologics manufacturing, and cell & gene therapy services. Comparable to BOC Sciences' CDMO/API business and mRNA manufacturing platforms, though at vastly larger scale and broader modality coverage.
  • Bio-Techne: Public life science tools company offering reagents, proteins, antibodies, and GMP-grade cytokines for research and cell therapy manufacturing. Comparable to BOC Sciences' GMP products and life science reagents portfolio with deeper biologics focus and stronger brand.

Emerging players

  • Bachem: Specialized CDMO focused on peptide and oligonucleotide API manufacturing with cGMP capabilities. Comparable to BOC Sciences' custom synthesis and CDMO capabilities for peptide-based and oligonucleotide chemistries, though with deeper specialization in peptide API manufacturing.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

BOC Sciences social profiles

Digital presence

BOC Sciences financial estimates

Financial estimate

Revenue estimate

Valuation estimate

BOC Sciences leadership team

Management profile

Number of profiles

BOC Sciences funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

BOC Sciences M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about BOC Sciences

What does BOC Sciences do?

BOC Sciences manufactures and supplies a broad catalog of research chemicals, pharmaceutical intermediates, impurities, metabolites, amino acids, nucleotides, oligonucleotides, enzymes, excipients, APIs, and GMP-compliant products for pharmaceutical, biotechnology, and academic research customers. It also delivers contract development and manufacturing organization (CDMO) services, custom synthesis, bioconjugation, analytical services, drug delivery solutions, and AI-powered drug discovery across advanced therapeutic modalities including PROTAC, ADC, RNA, and nanotechnology.

Is BOC Sciences a public or private company?

BOC Sciences is a private company. It is classified as unknown and is currently operating.

When was BOC Sciences founded?

BOC Sciences was founded in 2005. It employs 11 to 50 people.

Where is BOC Sciences based?

BOC Sciences is headquartered in Shirley, United States, in the North America region.

How does BOC Sciences make money?

Five revenue lines are on record. Research Chemicals & Products Sales are the primary driver. The others are custom Synthesis Services, CDMO Services, AI Drug Discovery Services and drug Delivery Solutions.

Who are BOC Sciences's main competitors?

Direct peers on record are WuXi AppTec, TCI Chemicals, Combi-Blocks, Bide Pharmatech and Santa Cruz Biotechnology. Broad incumbents are Sigma-Aldrich (Merck KGaA / MilliporeSigma), Catalent, Lonza and Bio-Techne. Bachem is listed as an emerging player.

Does BOC Sciences have an API?

No public API is recorded for BOC Sciences.

What industry is BOC Sciences in?

BOC Sciences's product category is Pharmaceutical Contract Manufacturing & Research Chemicals. Its primary akta.pro industry code is HLAIABAI, Contract Development & Manufacturing for Generics (CDMO/CMO), with a secondary code of HLAGAHAG, Impurity / Reference Standard Synthesis & Characterization. Its NAICS code is 3254 and its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
TalkMarketsNaphthol AS-LT Market to Reach USD 115.82 Million by 2032, Growing at 7.0% CAGRA market analysis published by 24chemicalresearch projects the global Naphthol AS-LT market will grow from USD 63 million in 2023 to USD 115.82 million by 2032, representing a 7.0% CAGR. Asia-Pacific dominates consumption with over 65% of global usage, driven by textile manufacturing hubs in China and India, while North America held a market size of USD 18.45 million in 2023. The report identifies key market players including A2B Chem, Angene, BOC Sciences, Biosynth Carbosynth, Chemwill Asia, Henan Tianfu Chemical, NBInno, Toronto Research Chemicals, and Career Henan Chemical, with growth driven by fast fashion demand and technical textile applications.TalkMarketsTetracosactide Market to Reach USD 156.4 Mn by 2032The global Tetracosactide market is projected to grow from USD 85.2 million in 2024 to USD 156.4 million by 2032, reflecting a compound annual growth rate of 6.8%. This expansion is driven by rising prevalence of adrenal disorders, advancements in peptide synthesis technology, and increasing demand for diagnostic tools in endocrinology. Key manufacturers identified in the market include Merck KGaA, Bachem Holding AG, Biosynth Carbosynth, LGC Limited, Santa Cruz Biotechnology, Abcam plc, Shimadzu Corporation, BOC Sciences, and ALB Materials Inc.BocsciCustom Synthesis Platform for Complex Molecules & ProcessesBOC Sciences offers custom synthesis services for complex molecules and processes, including GMP production for HPAPIs, APIs, and peptides. The company highlights its capabilities in synthetic route design, optimization, and scale-up chemistry to support drug development.BocsciFermentation for Natural SweetenersBOC Sciences promotes its bio-fermentation technology for producing natural sweeteners, highlighting advantages such as mild process parameters, lower costs, and high product purity compared to chemical hydrogenation. The company offers services including strain optimization and culture condition adjustment to maximize yield for compounds like erythritol and stevia glycosides.EIN PresswireBOC Sciences Integrates Its Glycan Technique Portfolio Into a New HubBOC Sciences has launched a new Glycan Portal to consolidate its portfolio of glycan-related reagents, synthesis services, and analytics tools for the scientific research community. The portal provides end-to-end solutions ranging from custom glycan synthesis and modification to glycoconjugate synthesis and production scale-up, targeting applications in biomarker discovery, ADC conjugation, and glycan-based therapeutics development. A company spokesperson stated the goal is to be a reliable partner in helping clients bring advanced therapeutics to market faster by overcoming synthetic and engineering challenges in glycobiology.BocsciComprehensive Chiral Catalyst SolutionsBOC Sciences offers comprehensive chiral catalyst solutions, including custom synthesis and various types of catalysts such as metal-based, polymer-supported, biocatalysts, and magnetic nano-catalysts. The company highlights the efficiency and enantioselectivity of these catalysts for synthesizing pharmaceutical intermediates and other complex compounds.BocsciHow Peptides Help Overcome ADCs Development Barriers?This article is an informational feature explaining how peptides can address technical challenges in antibody-drug conjugate (ADC) development, including tumor specificity limitations, linker stability issues, payload solubility problems, and manufacturing complexity. The piece describes three key roles for peptides in ADC design: as intelligent linkers enabling controlled drug release, as targeting ligands enhancing specificity, and as cytotoxic payloads themselves with improved solubility and biodegradability. BOC Sciences, a contract research organization, uses the article to promote its peptide synthesis, modification, and conjugation services for ADC development clients.BocsciLiposomes for Sunscreen IngredientsThe article discusses liposomal formulation technology used in sunscreens, highlighting its benefits such as enhanced stability, deeper skin penetration, and prolonged protection. BOC Sciences offers customized liposomal services, including formulation development, raw materials, encapsulation, and format engineering to improve UV filter performance.BocsciLiposomes for Scalp and Hair CareThe article discusses the development and application of liposomal formulations for scalp and hair care by BOC Sciences. These liposomal systems are designed to enhance the delivery, stability, and efficacy of active ingredients in various hair and scalp products.BocsciCell Therapy Formulation ServicesBOC Sciences is offering cell therapy formulation development services, focusing on creating high-quality formulations to ensure the efficacy and safety of cell therapies. The company customizes formulation designs based on the specific needs of different cell types, implements rigorous testing protocols, and emphasizes regulatory compliance to facilitate the transition from lab-scale development to mass production. This strategic support aims to expedite the development and market introduction of cell therapies.